Literature DB >> 19999956

Comprehensive exercise training improves ventilatory muscle function and reduces dyspnea perception in patients with COPD.

F Cortopassi1, A A M Castro, E F Porto, M Colucci, G Fonseca, L Torre-Bouscoulet, V Iamonti, J R Jardim.   

Abstract

BACKGROUND: Comprehensive exercise training (CET) is an efficient strategy to decrease dyspnea perception in chronic obstructive pulmonary disease (COPD) and may result in significant improvement in ventilatory muscles function. Our aim was to evaluate the effects of general exercise training on dyspnea perception and on respiratory muscles strength in COPD patients.
METHODS: Consecutive COPD patients were enrolled to complete a CET programme. The patients underwent a routine that included a global warm up, upper and lower limbs endurance exercise as well as stretching and relaxation. Before and after the CET programme, patients completed maximal inspiratory (PImax) and expiratory (PEmax) pressures measurements, maximal incremental test, endurance test, and 6-min walk distance (6MWD).
RESULTS: 71 patients (52 male). Mean age 67.6 +/- 8.6 years, FEV1 (%) 44.2 +/- 16.2 and Mahler dyspnea scale 6.4 +/- 1.8. The results before and after the exercise programme were: PImax 64.7 +/- 22.9 vs. 75.5 +/- 23.7 cmH2O (p=0.001), PEmax 110.8 +/- 28.1 vs. 120.4 +/- 28.1 cmH2O (p=0.004), 6MWD 510.6 +/- 90.3 vs. 528.2 +/- 99.7 metres (p=0.88), time of incremental test 672 +/- 135 vs. 856 +/- 226 sec (p<0.0001). Compared with the pre exercise programme, we observed a significant reduction on Borg dyspnea scale (6.1 +/- 2.8 to 3.6 +/- 2.3, p<0.0001) as well as a longer test time (504 +/- 218 to 1.038 +/- 841, p<0.0001) at the end of the endurance test after CET programme. Improvement of PImax correlated negatively with dyspnea perception at iso-time during the endurance test (r = -0.33, p=0.03).
CONCLUSIONS: Our results confirm that CET is associated with significant improvement in PImax, PEmax and provide evidence demonstrating that CET reduces dyspnea perception in patients with COPD.

Entities:  

Mesh:

Year:  2009        PMID: 19999956     DOI: 10.4081/monaldi.2009.355

Source DB:  PubMed          Journal:  Monaldi Arch Chest Dis        ISSN: 1122-0643


  6 in total

Review 1.  Comparison of laboratory- and field-based exercise tests for COPD: a systematic review.

Authors:  Iain Fotheringham; Georgina Meakin; Yogesh Suresh Punekar; John H Riley; Sarah M Cockle; Sally J Singh
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-03-19

2.  Association of physical activity with lung function in lung-healthy German adults: results from the KORA FF4 study.

Authors:  Agnes Luzak; Stefan Karrasch; Barbara Thorand; Dennis Nowak; Rolf Holle; Annette Peters; Holger Schulz
Journal:  BMC Pulm Med       Date:  2017-12-28       Impact factor: 3.317

3.  Effectiveness of water-based Liuzijue exercise on respiratory muscle strength and peripheral skeletal muscle function in patients with COPD.

Authors:  Weibing Wu; Xiaodan Liu; Jingxin Liu; Peijun Li; Zhenwei Wang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-05-25

Review 4.  Exercise Training in Patients with Chronic Respiratory Diseases: Are Cardiovascular Comorbidities and Outcomes Taken into Account?-A Systematic Review.

Authors:  Ana Machado; Kirsten Quadflieg; Ana Oliveira; Charly Keytsman; Alda Marques; Dominique Hansen; Chris Burtin
Journal:  J Clin Med       Date:  2019-09-13       Impact factor: 4.241

5.  Muscle metabolomics analysis reveals potential biomarkers of exercise‑dependent improvement of the diaphragm function in chronic obstructive pulmonary disease.

Authors:  Jian Li; Yufan Lu; Ning Li; Peijun Li; Jianqing Su; Zhengrong Wang; Ting Wang; Zhaoyu Yang; Yahui Yang; Haixia Chen; Lu Xiao; Hongxia Duan; Weibing Wu; Xiaodan Liu
Journal:  Int J Mol Med       Date:  2020-03-12       Impact factor: 4.101

Review 6.  Chemerin: A Potential Regulator of Inflammation and Metabolism for Chronic Obstructive Pulmonary Disease and Pulmonary Rehabilitation.

Authors:  Jian Li; Yufan Lu; Ning Li; Peijun Li; Zhengrong Wang; Wang Ting; Xiaodan Liu; Weibing Wu
Journal:  Biomed Res Int       Date:  2020-04-06       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.